UroGen Pharma (URGN) has an average rating of buy and mean price target of $41.62, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $40.31, Change: $+0.51, Percent Change: +1.28%